Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe ...
The results of two clinical trials—led by the Upstream Lab at St. Michael's Hospital in Toronto and Oxford University, ...
COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear. Research studies ...
FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19 ...
Over the last five years, billions of people have received at least one dose of a COVID-19 mRNA vaccine. New research has found an unanticipated result of these vaccines: Cancer treatments are more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results